Induction of anti-tumor activity following autologous stem cell transplantation: immunotherapeutic implications

Transplant Proc. 2001 Feb-Mar;33(1-2):2004-7. doi: 10.1016/s0041-1345(00)02769-x.

Authors

G H Marin¹, M E Menna, M I Bergna, J Malacalza, C Martin, M C Mendez, G Klein, L Montero-Labat, M A Gil, S Saba, L Gardenal, E Mansilla, S Orlando, C Canepa, G Piccinelli

Affiliation

¹ C.U.C.A.I.B.A., Ministry of Health, Buenos Aires, Argentina.

PMID: 11267604
DOI: 10.1016/s0041-1345(00)02769-x

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Acute Disease
Adult
Female
Graft vs Host Disease / diagnosis
Graft vs Host Disease / immunology*
Hematopoietic Stem Cell Transplantation*
Humans
Immunity, Cellular
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
Leukemia, Myeloid / immunology
Leukemia, Myeloid / therapy
Lymphoma / immunology
Lymphoma / therapy
Lymphoma, Non-Hodgkin / immunology
Lymphoma, Non-Hodgkin / therapy
Male
Middle Aged
Multiple Myeloma / immunology
Multiple Myeloma / therapy
Prospective Studies
T-Lymphocytes / immunology*
Transplantation, Autologous